2,000
Participants
Start Date
December 31, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
CGRP R Inhibitor; CGRP Inhibitor
Participants who are prescribed CGRP class drugs for the acute treatment of VM will be considered for inclusion in Group A1.Participants who are prescribed CGRP class drugs for the preventive treatment of VM will be considered for inclusion in Group B1.
none-CGRP
Participants who are prescribed none-CGRP class drugs for the acute treatment of VM will be considered for inclusion in Group A2.Participants who are prescribed none-CGRP class drugs for the preventive treatment of VM will be considered for inclusion in Group B2.
First People's Hospital of Hangzhou
OTHER
Sir Run Run Shaw Hospital
OTHER
Affiliated Hospital of Jiaxing University
OTHER
The People's Hospital of Quzhou
OTHER
The First People Hospital of Hangzhou Lin An District
UNKNOWN
Shaoxing People's Hospital
OTHER
Jiaxing Hospital of T.C.M
UNKNOWN
Hangzhou Hospital of Traditional Chinese Medicine
OTHER
Affiliated Wenling Hospital of Wenzhou Medical University
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Second Affiliated Hospital of Wenzhou Medical University
OTHER
Zhongshan Hospital Of Traditional Chinese Medicine
OTHER
The First People's Hospital of Huzhou
OTHER
Xin Hua Hospital of Zhejiang Province
OTHER
The Affiliated Hospital of Hangzhou Normal University
OTHER
Huzhou Central Hospital
OTHER
Chinese Medical University
UNKNOWN
Tiantai People Hospital
UNKNOWN
Zhejiang University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER